WHO ICTRP trial
A PHASE 2A, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY…
EUCTR2008-003572-21-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-003572-21-SE |
|---|---|
| Public title | A PHASE 2A, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY INVESTIGATING THE DOSE-RESPONSE OF PF-00489791 ON ACUTE HEMODYNAMICS IN SUBJECTS WITH IDIOPATHIC AND FAMILIAL PULMONARY ARTERIAL HYPERTENSION |
| Scientific title | A PHASE 2A, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY INVESTIGATING THE DOSE-RESPONSE OF PF-00489791 ON ACUTE HEMODYNAMICS IN SUBJECTS WITH IDIOPATHIC AND FAMILIAL PULMONARY ARTERIAL HYPERTENSION |
| Primary sponsor | Pfizer Ltd,Ramsgate Road,Sandwich,Kent CT13 9NJ |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany;Belgium;Spain;Sweden |
| Conditions | Pulmonary arterial hypertension. MedDRA version: 9.1 Level: LLT Classification code 10064911 Term: Pulmonary arterial hypertension |
| Interventions | Product Name: PF-00489791 Pharmaceutical Form: Film-coated tablet CAS Number: 853003-48-2 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 1- Pharmaceutical form of the placebo: Tablet Route of… |
| Registration date | Aug 25, 2008 |
| Target size | 79 |
| Secondary IDs | A7331009 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: